Ads
related to: pembrolizumab clinical trials- Manage Side Effects
View Tips for Managing Side
Effects From Your Treatment.
- Paying for KEYTRUDA
Find Assistance and Payment
Information for Certain Patients.
- How Does KEYTRUDA Work?
Learn About KEYTRUDA and How
It May Help Certain Patients.
- Taking KEYTRUDA
Learn More About Treatment
With KEYTRUDA Here.
- Manage Side Effects
Search results
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024...
Clearfield Progress· 5 days agoCo., Ltd. (Kosdaq: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable diseases ...
...Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with ...
Benzinga· 5 days ago(the "Company" or "Werewolf") HOWL, an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system ...
Immunotherapy significantly increases the number of patients free from bowel cancer: Clinical trial
Medical Xpress· 4 days agoThe trial was a collaboration among UCL, UCLH, the Christie NHS Foundation...
Promising HPV Cancer Treatment Advances in Clinical Trial By Investing.com
Investing.com· 2 days agoHOOKIPA Pharma Inc. (NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has reported...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
The Woonsocket Call· 5 days agoLilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in patients with KRAS ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days agoclinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced updated interim clinical ...
...-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 ...
The Morning Sun· 5 days agoCOPENHAGEN, Denmark & MAINZ, Germany--(BUSINESS WIRE)--Jun 1, 2024--Genmab A/S(Nasdaq: GMAB) andBioNTech SE(Nasdaq: BNTX) today announced initial data from the Phase 2 GCT1046-04 trial ( …
Sarcoma immunotherapy clinical trial reduces risk of relapse by 43%
Medical Xpress· 2 days agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare...
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 7 days agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
Clinical Trials Arena via Yahoo Finance· 3 days agoThe GCT1046-04 clinical trial is an open-label study evaluating the safety and efficacy of...
Ads
related to: pembrolizumab clinical trials